Tag: Science
Biotech Update: Roche’s TIGIT Struggles and Missed Alzheimer’s Target
Happy Tuesday! I'm Adam Feuerstein, and I'm here to bring you the latest updates in the world of biotech. It seems like all the big news in biotech decided to drop right before Thanksgiving,...
CRISPR Therapy Shows Superior Benefit for Cardiomyopathy Patients
Intellia Therapeutics CEO John Leonard has been facing a familiar situation for the past few years. The company has been sharing positive results from its gene editing trials, only to see its stock prices...
Seminal Moment for Science Journalism: A Letter from the Executive Editor
Dear Readers,I have written to you before to talk about the importance of subscribing to STAT for our comprehensive coverage of health and medicine. Today, I feel compelled to reiterate this message as we...
Title: Analysis of Alector Therapeutics’ Alzheimer’s Treatment Failure in Phase 2 Study
Alector Therapeutics announced that their Phase 2 trial for a potential Alzheimer's antibody, known as AL002, was unsuccessful. This setback is disappointing as the drug was considered a promising approach to treating the neurodegenerative...
Undetected Bird Flu Infections in Farmworkers: Study Reveals Risk
For several months now, the United States has been grappling with an outbreak of the H5N1 bird flu virus that has affected dairy cattle and led to human infections. A recent study has shed...
Top Medical Breakthroughs of 2024: A Comprehensive Guide to the Latest Innovations
Top Medical Breakthroughs of 2024: A Comprehensive Guide to the Latest InnovationsIn a year marked by incredible advancements in the field of medicine, 2024 has truly been a game-changer. From cutting-edge treatments for diabetes...
Optimistic Vaccine Activist: Embracing Hope for the Future
The United States is facing an uncertain future when it comes to vaccine policy. With potential appointees like Robert F. Kennedy Jr., Mehmet Oz, Jay Bhattacharya, and Joseph A. Ladapo, public health advocates are...
Reaction to Trump’s selection of RFK Jr. for HHS leadership
Leaders in the biopharma world and scientific community were taken aback by the news that President-elect Donald Trump has chosen Robert F. Kennedy Jr. to lead the Department of Health and Human Services. This...
Guidelines and Restrictions on Stem Cell-Based Embryo Models: A New Report
A new report from the Nuffield Council on Bioethics in the UK is calling for guidelines and restrictions on the use of stem cells to create embryo models that mimic aspects of embryonic development....
Medicaid Coverage of Obesity Drugs and Sickle Cell Trial Death: Pharmalittle Update
Good morning, everyone! We hope you're having a great day. Despite the cloudy skies here at Pharmalot, we're doing well and enjoying the autumn breeze. Today is an exciting day with millions of voters...
Interview with FDA’s Top Vaccine Regulator: Addressing Disinformation
The vaccination policy in the United States may be facing some significant changes, especially if Donald Trump is reelected and follows through on promises made by vaccine skeptic Robert Kennedy Jr. However, amidst concerns...
Roche Lung Cancer Study: Immunotherapy Failures and Drug Target Questions
Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a major lung cancer study. The study, known as SKYSCRAPER-01, involved...
